1. Home
  2. APGE vs SPNT Comparison

APGE vs SPNT Comparison

Compare APGE & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • SPNT
  • Stock Information
  • Founded
  • APGE 2022
  • SPNT 2011
  • Country
  • APGE United States
  • SPNT Bermuda
  • Employees
  • APGE N/A
  • SPNT N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • SPNT Property-Casualty Insurers
  • Sector
  • APGE Health Care
  • SPNT Finance
  • Exchange
  • APGE Nasdaq
  • SPNT Nasdaq
  • Market Cap
  • APGE 2.4B
  • SPNT 2.1B
  • IPO Year
  • APGE 2023
  • SPNT N/A
  • Fundamental
  • Price
  • APGE $55.35
  • SPNT $18.52
  • Analyst Decision
  • APGE Strong Buy
  • SPNT Buy
  • Analyst Count
  • APGE 8
  • SPNT 3
  • Target Price
  • APGE $94.63
  • SPNT $24.00
  • AVG Volume (30 Days)
  • APGE 923.1K
  • SPNT 512.4K
  • Earning Date
  • APGE 11-12-2025
  • SPNT 10-30-2025
  • Dividend Yield
  • APGE N/A
  • SPNT N/A
  • EPS Growth
  • APGE N/A
  • SPNT N/A
  • EPS
  • APGE N/A
  • SPNT 0.75
  • Revenue
  • APGE N/A
  • SPNT $2,793,700,000.00
  • Revenue This Year
  • APGE N/A
  • SPNT N/A
  • Revenue Next Year
  • APGE N/A
  • SPNT $6.45
  • P/E Ratio
  • APGE N/A
  • SPNT $24.21
  • Revenue Growth
  • APGE N/A
  • SPNT 3.57
  • 52 Week Low
  • APGE $26.20
  • SPNT $12.78
  • 52 Week High
  • APGE $63.50
  • SPNT $21.03
  • Technical
  • Relative Strength Index (RSI)
  • APGE 66.05
  • SPNT 53.65
  • Support Level
  • APGE $54.80
  • SPNT $17.88
  • Resistance Level
  • APGE $57.23
  • SPNT $18.58
  • Average True Range (ATR)
  • APGE 2.61
  • SPNT 0.50
  • MACD
  • APGE -0.18
  • SPNT 0.03
  • Stochastic Oscillator
  • APGE 62.75
  • SPNT 57.14

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About SPNT SiriusPoint Ltd.

SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.

Share on Social Networks: